UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 24, 2023
Accession Number:
0001193125-23-060233
Submission Type:
POS AM
CIK:
0001723128
Company Name:
Amneal Pharmaceuticals, Inc.
File Number:
333-263226